家
倫理的意思決定支援
哲学/宗教
28
28
功利主義と義務論の枠組みを用いて、ビジネス意思決定の道徳的影響を評価し、コンプライアンス助言を提供します。
プロンプト内容
コピー
コピー
Act as a corporate ethics consultant to assess the moral risks of the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but under-disclosed side effects with long-term use. Continuing sales maintains stock price and jobs for thousands, but hiding information may harm some patients. Analyze the ethical tension between utilitarianism's focus on overall well-being and deontology's emphasis on the duty of honesty, and provide balanced advice that balances legal compliance with corporate social responsibility, ensuring the output is a natural flowing paragraph rather than a list.
コピー
企業の倫理コンサルタントとして、以下のビジネスシナリオの道徳的リスクを評価してください。製薬会社が、長期使用後に軽微だが十分に開示されていない副作用を持つベストセラー医薬品を発見しました。販売を継続することは株価と数千の雇用を維持しますが、情報を隠すことは一部の患者に害を及ぼす可能性があります。全体的な幸福に焦点を当てる功利主義と、誠実さの義務を強調する義務論の間の倫理的緊張を分析し、法的コンプライアンスと企業の社会的責任のバランスを取るバランスの取れた助言を提供してください。出力はリストではなく、自然な流れの段落である必要があります。
コピー
コメント (0)
0/300
おすすめ
倫理的意思決定支援
Act as a corporate ethics committee to conduct a deep ethical assessment of the following specific business scenario: A major pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Combine the utilitarian principle of the greatest happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent to analyze the moral weight of three strategies: concealing information, issuing public warnings, or initiating a recall. Avoid simple right-or-wrong judgments; instead, construct a multi-dimensional evaluation framework including stakeholder impact, legal risks, brand reputation, and social trust. Finally, output an advisory action guide that aims to balance business sustainability with patient welfare, ensuring the decision-making process is transparent and adheres to the highest ethical standards.
倫理的意思決定支援
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has minor but non-fatal side effects with long-term use, yet a recall would bankrupt the company and lay off thousands. Evaluate the ethical weights of recalling versus not recalling by combining utilitarian calculations for the greatest good with deontological respect for human dignity, and provide a specific action plan that balances social responsibility with corporate survival, focusing on how to build public trust through transparent communication.
倫理的意思決定支援
Act as a corporate ethics consultant to analyze the moral dilemma in the following business scenario: A pharmaceutical company discovers that its best-selling drug has minor but negligible side effects with long-term use, yet discontinuing it would cause some patients' conditions to worsen. Please weigh the benefits of disclosure against the risks of concealment, combining utilitarian consequence assessment with deontological respect for informed consent. Finally, provide a specific action plan that balances patient safety, corporate reputation, and legal compliance, focusing on how to maintain trust through transparent communication while minimizing potential harm.
倫理的意思決定支援
Act as a corporate ethics consultant to conduct a deep moral deduction on the following specific business scenario: A pharmaceutical company discovers that its marketed drug has mild but irreversible neurological side effects with long-term use, yet stopping medication carries higher risks and alternative therapies are less effective. Please analyze the ethical weight of four strategies—disclosing information, adjusting pricing, reformulating, or withdrawing from the market—by balancing utilitarian calculations for the greatest good against deontological adherence to patient知情权 and non-maleficence. Provide a final action recommendation that balances business sustainability with social responsibility, focusing on how to build trust through transparency and patient safety.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its long-listed common drug may cause severe side effects in a very small group of patients with specific genetic profiles, but the recall cost is extremely high and could lead to drug shortages affecting the majority of patients. Please evaluate the moral rationality of three options—full recall, partial recall, or continued sales—by combining the utilitarian principle of maximizing happiness with the deontological obligation to respect individual rights and the duty of honest disclosure. Provide the best course of action that balances the interests of all parties and aligns with corporate social responsibility, focusing on the ethical trade-off logic in the decision-making process.
倫理的意思決定支援
Act as a corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but predictable side effects with long-term use, yet stopping production would leave millions of dependent patients without basic treatment. Please evaluate whether the drug should be voluntarily recalled by combining the utilitarian principle of the greatest happiness for the greatest number with the deontological duty to honestly inform patients of risks. In your analysis, weigh shareholder interests, patient safety, legal compliance, and social trust, and provide a specific action recommendation that balances ethical responsibility with business sustainability, avoiding abstract theoretical stacking and focusing on the practical execution level of ethical trade-offs.
